8-K: Blade Air Mobility Announces First Full-Year Adjusted EBITDA Profitability in Q4 2024 Results

Blade Air Mobility reports improved full-year net loss and Adjusted EBITDA, driven by growth in the Medical and Passenger segments, and reaffirms guidance for double-digit millions of Adjusted EBITDA in 2025.

Summary

• Blade Air Mobility announced its Q4 2024 and full-year 2024 financial results.
• The company's full-year net loss improved by $28.8 million to $(27.3) million compared to the prior year.
• Adjusted EBITDA for the full year improved by $17.8 million to $1.2 million.
• Passenger Segment Adjusted EBITDA for the full year was $3.6 million, an $8.6 million increase year-over-year.
• Q4 revenue increased by 14.5% to $54.4 million; excluding Canada, revenue increased by 22.1%.
• Net loss for Q4 improved by $24.1 million to $(9.8) million.
• Adjusted EBITDA for Q4 improved by $4.9 million to $(0.4) million.
• Medical Segment Adjusted EBITDA improved by 119.6% to $5.5 million in Q4.
• The company reaffirmed its guidance for double-digit millions of Adjusted EBITDA in 2025.
• Blade ended FY 2024 with $127.1 million in cash and short-term investments.
• For the full year 2025, Blade expects revenue of $245-265 million and double-digit Adjusted EBITDA.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with improved financial performance and a clear strategy for future growth. The achievement of Adjusted EBITDA profitability is a significant milestone. However, the company is still loss making and faces risks associated with the transition to new technologies and market conditions.

Positives

• The company achieved its first full year of Adjusted EBITDA profitability.
• Significant improvement in net loss for both the full year and Q4.
• Strong growth in Medical Segment Adjusted EBITDA.
• Revenue growth in both Passenger and Medical segments.
• Successful positioning of both Medical and Passenger businesses to benefit from improved economies of scale.
• Early results from European restructuring are encouraging.
• Launch of a pilot program with Skyports Infrastructure to expand helicopter transfer service.
• Introduction of a new mobile app with an enhanced user experience.

Negatives

• The company still reported a net loss for both Q4 and the full year, although significantly improved from the prior year.
• Adjusted EBITDA was still negative in Q4, although improved year-over-year.
• Short Distance revenue decreased 14.7% in Q4, although it increased 17.7% excluding Canada.

Risks

• The company acknowledges risks related to the shift to EVA technology.
• The company acknowledges risks related to accidents involving small aircraft, helicopters or charter flights.
• The company acknowledges risks related to competition.
• The company acknowledges risks related to economic conditions.
• The company acknowledges risks related to climate change.
• The company acknowledges risks related to system failures, defects, errors, or vulnerabilities in our website, applications, backend systems or other technology systems or those of third-party technology providers.
• The company acknowledges risks related to interruptions or security breaches of our information technology systems.
• The company acknowledges risks related to regulatory obstacles in local governments.
• The company acknowledges risks related to the expansion of domestic and foreign privacy and security laws.
• The company acknowledges risks related to the expansion of environmental regulations.

Future Outlook

Blade expects revenue of $245-265 million and double-digit millions of Adjusted EBITDA for the full year 2025.

Management Comments

• Rob Wiesenthal, Blade's CEO, stated that the company is pleased to deliver its first full-year of Adjusted EBITDA profitability.
• Rob Wiesenthal, Blade's CEO, stated that the company is focused on maximizing growth in Urban Air Mobility products.
• Will Heyburn, Blade's CFO, stated that the company has successfully positioned both the Medical and Passenger businesses to benefit from improved economies of scale.
• Will Heyburn, Blade's CFO, stated that Q4 2024 was the first quarter with Medical Segment Adjusted EBITDA margins above the 15% near-term target.
• Melissa Tomkiel, Blade's President, stated that early results following the European restructuring have been very encouraging.
• Melissa Tomkiel, Blade's President, stated that aircraft investments continue to provide much more than just financial benefits.

Industry Context

Blade's focus on Urban Air Mobility and its transition to eVTOL aircraft aligns with the broader industry trend towards sustainable and efficient air transportation. The company's partnerships, such as the one with Skyports Infrastructure, are indicative of the collaborative efforts needed to develop the infrastructure for future air mobility solutions.

Comparison to Industry Standards

• It is difficult to compare Blade directly to other companies due to its unique business model, which combines passenger and medical transport.
• However, comparing Blade to pure-play helicopter or air transport companies, a 0.5% Adjusted EBITDA margin is low but represents a significant improvement.
• Companies like Bristow Group (VTOL) or Era Group (ERA) operate in similar markets, but their financial performance and business models differ significantly.
• Blade's focus on urban air mobility and eVTOL transition sets it apart from traditional helicopter operators.

Stakeholder Impact

• Shareholders will likely react positively to the improved financial performance and the achievement of Adjusted EBITDA profitability.
• Employees may benefit from the company's growth and expansion.
• Customers will benefit from the improved services and new offerings.
• Suppliers and creditors will benefit from the company's improved financial stability.

Next Steps

• The company will continue to focus on growing its Urban Air Mobility products.
• The company will continue to drive further cost efficiencies in its Passenger business.
• The company will launch a pilot program with Skyports Infrastructure.
• The company will launch with two new transplant centers in April.
• The company will focus on aircraft investments and additional capacity purchase agreements to drive margin expansion.

Key Dates